Description
Matrix GLa protein inhibits vascular calcification in a vitamin K-dependent manner. Serum levels of this peptide may be used as a biomarker for renal failure, diabetes, and cardiovascular events.
| Product Unit Size | Cost | Quantity | Stock |
|---|
Matrix GLa protein inhibits vascular calcification in a vitamin K-dependent manner. Serum levels of this peptide may be used as a biomarker for renal failure, diabetes, and cardiovascular events.
| Purity | ≥95% |
|---|---|
| Formula | C18H25N5O5S |
| Formula Wt. | 423.4 |
| Synonym | MGP-pNa |
| Solubility | Soluble in water. |
| Appearance | White to off white powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
McCarty MF, DiNicolantonio JJ. The molecular biology and pathophysiology of vascular calcification. Postgrad Med. 2014 Mar;126(2):54-64. PMID: 24685968.
Schurgers LJ, Uitto J, Reutelingsperger CP. Vitamin K-dependent carboxylation of matrix Gla-protein: a crucial switch to control ectopic mineralization. Trends Mol Med. 2013 Apr;19(4):217-26. PMID: 23375872.
Mycotoxin produced by species of Aspergillus; D...
Smo inhibitor.
Secoiridoid glycoside found in Gentiana and Cep...
Peptide, contains two cell-penetrating sequence...
AChE inhibitor.
Diterpenoid found in Rabdosia rubescens; potent...
mTOR inhibitor.
Synthetic progestogen; PR agonist.
Kawain derivative, lactone found in Piper methy...
Efflux pump inhibitor
Glutathione-ITC conjugate, antioxidant.
Polyphenol found in Gossypium; calcineurin and ...
Pyrimidine nucleoside (cytidine) analog; DNA ch...
Endogenous sterol component of animal cell memb...
Src and Abl inhibitor.
Polyphenol derivative of caffeic acid found in ...
PKC activator, carcinogen.
Endogenous thyroid hormone T4.
Mycotoxin that has structural similarity to est...